Clinical trial
Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer
NCT00003108 · Lombardi Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003108 |
|---|---|
| Title | Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer |
| Official title | A Phase I Study of Bryostatin and Cisplatin in Patients With Advanced Cancer |
| Lead sponsor | Lombardi Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | bryostatin 1, cisplatin |
| Start date | Oct 1, 1997 |
| Completion | Oct 1, 2007 |
| First posted | Feb 9, 2004 |
| Last update posted | Jul 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: